Unknown

Dataset Information

0

Altered brain regional homogeneity is associated with depressive symptoms in COVID-19.


ABSTRACT:

Background

COVID-19 is an infectious disease that has spread worldwide in 2020, causing a severe pandemic. In addition to respiratory symptoms, neuropsychiatric manifestations are commonly observed, including chronic fatigue, depression, and anxiety. The neural correlates of neuropsychiatric symptoms in COVID-19 are still largely unknown.

Methods

A total of 79 patients with COVID-19 (COV) and 17 healthy controls (HC) underwent 3 T functional magnetic resonance imaging at rest, as well as structural imaging. Regional homogeneity (ReHo) was calculated. We also measured depressive symptoms with the Patient Health Questionnaire (PHQ-9), anxiety using the General Anxiety Disorder 7-item scale, and fatigue with the Multidimension Fatigue Inventory.

Results

In comparison with HC, COV showed significantly higher depressive scores. Moreover, COV presented reduced ReHo in the left angular gyrus, the right superior/middle temporal gyrus and the left inferior temporal gyrus, and higher ReHo in the right hippocampus. No differences in gray matter were detected in these areas. Furthermore, we observed a negative correlation between ReHo in the left angular gyrus and PHQ-9 scores and a trend toward a positive correlation between ReHo in the right hippocampus and PHQ-9 scores.

Limitations

Heterogeneity in the clinical presentation in COV, the different timing from the first positive molecular swab test to the MRI, and the cross-sectional design of the study limit the generalizability of our findings.

Conclusions

Our results suggest that COVID-19 infection may contribute to depressive symptoms via a modulation of local functional connectivity in cortico-limbic circuits.

SUBMITTER: Cattarinussi G 

PROVIDER: S-EPMC9233546 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>COVID-19 is an infectious disease that has spread worldwide in 2020, causing a severe pandemic. In addition to respiratory symptoms, neuropsychiatric manifestations are commonly observed, including chronic fatigue, depression, and anxiety. The neural correlates of neuropsychiatric symptoms in COVID-19 are still largely unknown.<h4>Methods</h4>A total of 79 patients with COVID-19 (COV) and 17 healthy controls (HC) underwent 3 T functional magnetic resonance imaging at rest, as  ...[more]

Similar Datasets

| S-EPMC7376105 | biostudies-literature
| S-EPMC8187583 | biostudies-literature
| S-EPMC10631123 | biostudies-literature
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
| S-EPMC10303328 | biostudies-literature
| S-EPMC9593212 | biostudies-literature
| S-EPMC5990869 | biostudies-literature
| S-EPMC7928375 | biostudies-literature
| S-EPMC9201242 | biostudies-literature
| S-EPMC4631949 | biostudies-literature